Dancehall artiste Caboowie is expressing concern about the frequent incidents of violence among school children. “You see how ...

QD 5:2 selected as azenosertib monotherapy pivotal study dose based on favorable benefit-risk profile in DENALI Part 2a, supporting advancement in registration-intended trialsDENALI Phase 2 trial ...

Since April 2025, practices such as fake reviews, undisclosed incentivised reviews and misleading star ratings have been classed as banned practices. The Competition and Markets Authority ("CMA") now ...

Bolting AI onto your product willy-nilly can hurt more than it helps. Experts weigh in on common mistakes around AI feature ...

Q2 2026 Guidance -- Billings projected between $61 million and $67 million, revenue between $35 million and $40 million, ...

Outbound faces a rocky launch, further complicated by unexpected Steam review controversies.

Brand perception is increasingly central to how consumers decide which products and services to trust and purchase. As ...

Phase 1 clinical data in patients with Parkinson’s disease demonstrating reduction in endolysosomal and neuroinflammatory ...

Bank of America Global Healthcare Conference 2026 May 12, 2026 8:01 PM EDTCompany ParticipantsJeffrey Finer - Co-Founder, CEO ...

Wednesday, May 13, 2026 at 8:30 a.m. ET Total Revenue -- $16.9 million, declining 10.1% year over year due to macroeconomic ...

Kyntra Bio, Inc. (NASDAQ: KYNB) Q1 2026 Earnings Call Transcript May 11, 2026 Kyntra Bio, Inc. misses on earnings expectations. Reported EPS is $-3.76 EPS, expectations were $-3.36.

First-ever FDA approved PROTAC supports the further development and potential of Arvinas' pipeline - - Announced FDA Approval of VEPPANU (vepdegestrant) for the treatment of ESR1m, ER+/HER2- advanced ...